Try our Advanced Search for more refined results
Life Sciences - March, 2022
327 articles
- $640M Question: 'What Did McKinsey Get' In Big Opioid Deal?
- 3rd Circ. Lets Merck Arbitrate Antitrust Suit Over Vax Prices
- Fed. Circ. Forecast: Cisco To Seek Recusal After $2.7B Loss
- Arbitration-Winning Nutritional Co. Wants $1M In Fees Vacated
- Actavis Must Face Sanctions For Withholding Docs, Man Says
- USTR Cools On Trump-Era China Deal Amid Strategy Pivot
- Becton Dickinson Can't Trim Baxter's Med Pump Patent Suit
- What's Notable In DOJ's 1st Cyber-Fraud Initiative Settlement
- Fla. Hospitals Seek Stay Of State's $65M Endo Opioid Deal
- USPTO Director Review Is A Rare Remedy After Arthrex
- Health Plans Squeezed By Opioid Drug Scheme, 3rd Circ. Told
- Unrepentant Priest Faces 5-Year Injunction In SEC Fraud Case
- 5 Mediation Mistakes That Create Obstacles To Settlement
- Hard-Hit W.Va. Eyes 'Day Of Fate' In Imminent Opioid Trial
- Balwani 'Angry' At Quality Control Advice, Theranos Jury Told
- 6th Circ. Upholds Remand Of Opioid Coverage Dispute
- Fed. Circ. Grills USPTO On Hirshfeld's Power In Arthrex Fight
- Appeals Of J&J Talc Unit's Ch. 11 Heading Directly To 3rd Circ.
- The Problem With GOP Attack On Jackson Immigration Ruling
- Legal Head Of Medical Association Bows Out After 4 Decades
- Biotech Co. Misled Investors About Kidney Drug, Suit Says
- Stroock Adds Patent Litigation Co-Chair From Arnold & Porter
- Faegre Drinker Vet Departs For Philly's Tucker Law Group
- Fla. Inks More Than $878M In Opioid Deals Ahead Of Trial
- Theranos Judge Seals Courtroom For Balwani's Brady Hearing
- Medical Device Group Seeks Win In Copyright Office Suit
- Gilead Can't Force Aetna HIV Suit On Its Terms
- Bill Would Make Contractors Disclose Potential Conflicts
- Biotech Co.'s Creditor Wants In On $3.8M Award Dispute
- Purdue Victims Ask 2nd Circ. To Reverse Ch. 11 Plan Rejection
- FDA Greenlights 2nd COVID Boosters For Some Groups
- German Leader Favors Protecting Patents In WTO Debate
- Emergent Derivative Suit Stayed In Del. Pending Md. Action
- Boston Global Lands $543M In Financing For Mixed-Use Tower
- Fla. High Court Suspends Patent Attorney For 3 Years
- What OIG Rule Change Means For Health Care Innovation
- Cooley Adds Linklaters Antitrust Head To Brussels Office
- Norton Rose Fulbright Adds Commercial Partner In Texas
- Titan Of The Plaintiffs Bar: Simmons Hanly's Jayne Conroy
- $127B HHS 2023 Budget Highlights Vax Access, Mental Health
- Pharmacies Ask 10th Circ. To Stop Cherokee Opioid Suit Move
- Illumina Wins Injunction, Loses Triple Damages In BGI IP Case
- Former MiMedx CFO Can't Escape SEC's Fraud Suit
- FDA Seeks $8.4 Billion For 2023 Budget
- Takeaways From Holmes' Unsuccessful Trade Secret Defense
- Attys From Two Firms To Co-Lead CPAP Cleaner MDL
- Claim Of Misuse Of Insys Docs Struck As Bid To 'Taint' Atty
- Ex-NuVasive Rep Must Pay $1.6M For Noncompete Breach
- Law360 Reveals Titans Of The Plaintiffs Bar
- Ethics Principles Call For Justice Thomas Recusal On Election
- Cannabis Data Firm Says Federal Reform A Long Way Off
- Sacklers Say New Ch. 11 Plan Boasts 'Extraordinary' Support
- Holland & Knight Wins Back Litigation Pro From Boutique
- Teva Can't Toss Securities Suit Over Alleged Drug Kickbacks
- 9th Circ. Asked To Rehear Prop 65 Acrylamide Warning Ruling
- Cannabis Bill Roundup: MORE Act To Get Another Floor Vote
- EU, Turkey Agree To Arbitrate Appeals In WTO Clashes
- Merck's Gardasil Vaccine Caused Ga. Teens' Illness, Suits Say
- Fed. Circ. Revives ImmunoGen's Cancer Treatment Patent App
- UK Litigation Roundup: Here's What You Missed In London
- Buchanan Ingersoll Says 'Privileged' Docs' Clawback Too Late
- Kirkland-Led Huntsman Beats Starboard At The Election Box
- Cooley, Davis Polk Rep Lung Disease Biopharma's $69M IPO
- 5 Ways Law Firm Leaders Can Prioritize Strategic Thinking
- Fla. Doctor Convicted Of $112M Drug Treatment Billing Fraud
- Alcon Reaches $20M Lens Price-Fix Deal, Leaving Only J&J
- NJ Pot Regulators OK First Conditional Adult-Use Permits
- IP Forecast: Fed. Circ. To Mull Arthrex's Latest USPTO Fight
- Vitamin C Cos. Ask Justices To Save Price-Fixing Case Again
- Senate Approves Marijuana And CBD Research Bill
- J&J Talc Unit Opposes Claimants' 3rd Circuit Appeal Request
- Texas Deepens Puberty-Blocker Probe Into Endo And AbbVie
- Ranbaxy Confirms 'Global' Deal Resolving Antitrust MDL
- Judge Hands Win To Sandoz In Patent Row With Genentech
- HHS Again Urged To Use March-In Rights To Cut Drug Costs
- DLA Piper Snags 2 Corporate Partners From Faegre Drinker
- Endo Wins Dismissal Of FTC's Suit Over Impax Opioid Deal
- AndroGel Buyers Can't Use FTC Case Against AbbVie, Besins
- Mallinckrodt Creditor Payments Won't Be Held For Appeals
- Cannabis M&A Remains On Fire With $93.3M APIRx Deal
- How Law Schools Can Navigate Toward Equity And Inclusion
- Tearful Theranos Whistleblower Says Boies Threatened Suit
- Opioid MDL Bellwether In SF Gets 'Shocking' Cut To Trial Time
- Moderna Will Seek FDA Approval For Low-Dose Vax For Kids
- Kidney Care Co. Mismanaged Retirement Plan, Suit Says
- Cherokee Opioid Bellwether Suit Is Moved To State Court
- Doctors' Worries Over PE Deals Dominate Merger Comments
- Takeda Asks Fed. Circ. To Undo Trintellix IP Loss
- Shareholders Say Medrobotics Execs Hid Devastating IP Suits
- From Alice To Fintiv: Judge O'Malley Dishes On Patent Law
- US Reinstates Tariff Cuts For More Than 350 Chinese Products
- Where Judge Jackson Stands On Key Civil Procedure Issues
- A Look At Jackson's False Claims Act Jurisprudence
- FDA's Proposed Medical Device Rule Is Promising, But Hasty
- Merck Wins Preemption Ruling In Fosamax Warning MDL
- What DOJ's Shifting Stance On IP Means For SEPs, Mergers
- Attys Seek $4M Fee For BridgeBio Board Pay Suit In Chancery
- Ranbaxy Settles MDL Antitrust Claims For $485M
- SmileDirectClub Can't Nix Claims It Misled On Compliance
- Purdue Gets Another Opioid Suit Freeze Amid Ch. 11 Appeal
- Pharmacy Attys Risking Opioid MDL Sanctions, Judge Warns
- Balwani Blames Holmes As 2nd Theranos Fraud Trial Opens
- Pharma Co. Exits Latest Investor Suit Over Liver Disease Drug
- Trial In Georgia Over Families' Opioid Claims Is Delayed
- 8th Circ. Asked To Follow The 9th In Flavored Vape Ban Case
- Abbott Can't Ax False Ad Attack In Probiotic IP Row
- Zimmer Biomet Bribery Suit Belongs In Mexico, 7th Circ. Says
- Ex-Pfizer Execs Deny Taking Trade Secrets To Their Startup
- Latham-Led Cancer Treatment Co. Wraps Up $175M Financing
- Conn. Atty Enriched Self With Sham Stock Sales, Jury Hears
- Drug Maker Stole COVID Vax Trade Secrets, $950M Suit Claims
- Justices Skip $420M Secrets Suit, 'Candy Colors' Fight & More
- Sick Juror Gets Cut On Eve Of Ex-Theranos Exec's Fraud Trial
- Becton Dickinson Urges Justices To Reject Baxter's IP Petition
- Boston Hotel Fights Insurer's Win Bid In Virus Coverage Suit
- Fla. Bros. Get Prison For $112M Drug-Treatment Billing Fraud
- Monsanto Seeks High Court Review Of $87M Roundup Verdict
- Amgen Agrees To End Neulasta IP Suit Against Pfizer, Hospira
- 7th Circ. Won't Revive Becton Buyers' Antitrust Suit Again
- Cooley-Led Biopharm Startup Plans For $60M IPO
- DC Group Backs Pharma Cos. In Niaspan Pay-For-Delay Case
- Bioscience Co. Settles Challenge To $70M Private Placement
- Teva Strikes $100M Deal, Ends Rhode Island Opioid Trial
- Catching Up With Delaware's Chancery Court
- How To Avoid Prematurely Publicizing A Case Outcome
- Working With Post-Pandemic Juries On Science-Based Cases
- Bad Bargain? Old Opioid Deal Haunts Fla. AG As Trial Nears
- Mediators Appointed For J&J Talc Unit's Ch. 11 Plan Talks
- Bristol-Myers Sues AstraZeneca Over Cancer Drug Patents
- Fed. Circ. Won't Revive Boston Scientific Implant Patent
- Shkreli Can't Press Pause On $64M Antitrust Judgment
- DC Judge Ends 'Dormant' LabMD Suit Against FTC Attys
- Pfizer Vaccine Delivery Designer Wants Rival's Patents Axed
- Zimmer Can't End Rival's IP Suit Over Knee Replacement Tech
- 5 Steps For Counsel Managing Health Care Data Breaches
- Health Hires: Opentrons Labworks, Conformis
- 9th Circ. Blocks New Prop 65 Acrylamide Warning Label Suits
- IP Forecast: Google To Fight Sonos' Last-Minute Changes
- Mediation Gag Order On Tap For J&J Talc Unit And Claimants
- 9th Circ. Partially Revives SmileDirect's Dental Board Suit
- Human Cell Medical Co. Sues HHS Over Product Reg Dispute
- Jointly, A Pot Ratings App, Raises $5M In Seed Funding
- Latham-Led Triumvira Immunologics Clinches $100M Series A
- Illumina Says Its Ex-Scientists Used Stolen IP To File Patents
- Addressing Patient Requests For Unauthorized Treatment
- How To Wind Down Patents In Russia Over Next 3 Months
- Novartis Loses Bid To Make FDA Block Patent Term Extension
- Rival Says Pfizer And Moderna Vaccines Rely On Its IP
- Roche Unit Nets $775M Deal In AstraZeneca IP Row
- Chancery Sends Stimwave Battle With Founder Toward Trial
- It's Time To Hold DC Judges Accountable For Misconduct
- Goodwin Bulks Up IP Medtech Team In Boston
- Enviro Groups Seek $1.9M Fees In Gene-Modified Salmon Row
- Drug Purchasers Seek Blessing Of Sun And Taro Deals
- COVID IP Waiver Compromise Bashed By All Sides
- Fed. Circ. Won't Review 2 IP Axes Over Written Description
- Daiichi Sankyo Hit With $75K Legal Bill Before Patent Trial
- Husch Blackwell Debuts Psychedelics Practice Team
- Rhode Island AG Opioid Trial Pushed Back
- BCBS Stays In Gilead HIV Suit As More Than An Intermediary
- Health Plans Sue Walgreens Over Prescription Drug Prices
- PTAB Axes Most Of Boston Scientific Rival's Spine Patents
- How To Mitigate Sentencing Liability In Complex Fraud Cases
- J&J Beats Investor's Arbitration Proposal Fight — Again
- NuVasive Nets $1.15M In Spinal Surgery Patent Trial
- Biotech Founders Get 1 Year Each For Stealing Genentech IP
- Balwani Trial Openings Delayed Due To COVID-19 Exposure
- Clifford Chance Adds Hogan Lovells Antitrust Law Expert
- EU, India, South Africa, US Reach Vaccine TRIPS Waiver Deal
- Jury Empaneled In Ex-Theranos Exec Balwani's Fraud Trial
- Long Beach, Others Win OK Of $550M Monsanto PCB Deal
- Akebia Hit With Investor Suit Over Anemia Drug Disclosure
- Del. Judge Trims Purification Patent Suit Against Bio-Rad
- Judge Won't Toss Teva's Migraine Drug IP Suit Against Eli Lilly
- WSJ Again Seeks Release Of Holmes Mental Health Docs
- Deploying Forum Selection Clauses To Bar PTAB Challenges
- Pa. Bio Cos. End Gene Therapy Row In Deal Worth Up To $75M
- Natera Gets Mixed Rulings In Cancer Test Patent Suits
- States Fight Shkreli's Bid To Pause Monetary Penalty
- Full Fed. Circ. Told To Take Crack At Split Narcan Ruling
- Jury Hits Natera With $45M Verdict In CareDx False Ad Suit
- Disney, Walmart Among Cos. Graded F On Pay Gap Disclosure
- 4 Ways To Preserve Confidentiality Of Litigation Funding Docs
- J&J Unit Hit With $20M Verdict In Knee Replacement IP Trial
- How A Drug Co.'s Misreporting Earned A Whistleblower $40M
- McKesson Didn't Rubber-Stamp Opioid Orders, Ex-Exec Says
- Fed. Circ. Was Right To Deny Amgen IP 'Gambit,' Justices Told
- Sensipar Antitrust Claims Trimmed In Amgen, Teva MDL
- Judge OKs $264M Deal Ending Mylan EpiPen Price-Hike Suit
- J&J Investor Fights Arbitration Proposal 'Misstatements'
- CBD Retailer, Manufacturer Denied Sanctions In Patent Row
- Fed. Circ. Affirms PTAB's Ax Of Acne Drug Patent
- Arthrex Says Qualcomm Case Sinks Invalidity Ruling
- Drafting Negative Limitations After Novartis Patent Ruling
- Catching Up With Delaware's Chancery Court
- Navigating Risks In FDA's New Digital Health Tech Guidance
- AMA Hires Ex-IBM Top Health Atty As General Counsel
- Remote Hearings Are Ill-Suited Default For Litigation Realities
- Key Opioid Cases To Watch As Massive Wave Of Trials Looms
- 6th Circ. Orders Opioid MDL Judge To Unfreeze Cases
- Data Co. IQVIA Can't Dispute Trade Secrets Misappropriation
- AOP Orphan Wants Remnants Of €142M Award OK'd In Mass.
- Balwani Wants Altered Theranos Pharma Reports Out Of Trial
- DuPont Can't Shake Fla. Town's Foam Contamination Suit
- Schools End Opioid Claims Against J&J, Distributors
- Cannabis Bill Roundup: Del. Legalization Bill Fails
- 5th Circ. Keeps Medtronic's Win In Defective Device Suit
- 2nd Circ. Backs Dismissal of Bristol-Myers Clinical Trial Suit
- Imerys, Cyprus Extend Mediation On Ch. 11 Talc Settlement
- Air Force Says Ga. Officer Can't Bring Class Claims In Vax Suit
- Astellas Can't Cut Scientists From Stem Cell Patent Apps
- Stays Pending IPR In Del. District Courts Are Here To Stay
- Full Fed. Circ. Asked To Undo Forum Selection Clause Ruling
- ABA's New Anti-Bias Curriculum Rule Is Insufficient
- Don't Miss It: Davis Polk, Paul Weiss Guide Week's Hot Deals
- Moderna's Top Lawyer Saw Pay Near $11.5M Last Year
- Health Hires: Proskauer, Trilogy Health, Pillar Biosciences
- Ill. Emissions Ruling May Hamper Policyholders, Experts Say
- Media Exposure To Holmes Trial Narrows Balwani Jury Pool
- Bausch, Salix's Trimmed IBS Drug IP Suit Moves to W.Va.
- 9th Circ. Won't Revive McKesson Whistleblowers' FCA Suit
- US Senate Confirms María Pagán As WTO Envoy
- Biden Urged To Use Defense Law To Boost Renewable Energy
- 5 Russian, Ukrainian Patent Updates You May Have Missed
- Couple Will Pay $4.6M To End SEC's Insider Trading Claims
- Opioid Victims Get Chance To Confront Sacklers In Court
- 9th Circ. Judges Call COVID Liability Ruling A 'Game Changer'
- Fed. Circ. Gives 7 Patent Appeals Quick Closure
- Drug Patent Critic Hits Back At Claims Research Is Flawed
- Comparing FDA Medical Device Proposal With Global Rules
- Immunotherapy Co. Must Pay NY Broker $2.5M Arb. Award
- Anti-Kickback Safe Harbors May Be Less Safe After Medtronic
- US Judge Finds Conn. Atty Liable For Illegal Stock Sales
- Ex-McDermott Partner Joins O'Melveny Liability Group In NY
- Deals Rumor Mill: Deutsche Telekom, Amazon, Merck
- 2 Firms Rep As Bayer Sells $2.6B Pest Control Biz To PE Firm
- Balwani Jury Prospects Talk Ukraine War, Elizabeth Holmes
- Fed. Circ. Examines Invalidation Of Sanofi Injector Pen Patent
- Tribes Say States Owe Them Part Of Purdue's New $5.5B Deal
- Mass. Rep. Seeks To Destigmatize Medical Pot Use In Vets
- Sheppard Mullin Nabs 5 Life Sci Pros From Loeb & Loeb
- Purdue Gets Approval For New $5.5B Ch. 11 Sackler Deal
- Philips Faces Refund Suit Over Recalled CPAP Devices
- CDC Told To Keep Story Straight In HIV Patent Fight
- Nothing 'Innocuous' In Drugmakers' Dismissal Bid, Court Told
- Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023
- Fake Vax Seller Nabbed In Sting Dodges Prison
- 5 Advertising Enforcement Trends To Watch
- Lando & Anastasi Life Sciences Leads Join K&L Gates
- Remote Hearings Should Be The Default In Civil Litigation
- Ill. Company Shut Down Over Tainted Supplements
- Wash. AG's Opioid Trial Survives 'Very Significant' Defenses
- UnitedHealth's HIV Drug Suit Against Teva, Gilead Trimmed
- Jones Day Can Stay As J&J Talc Spinoff's Ch. 11 Counsel
- Possible Holmes Testimony Hangs Over Sunny Balwani's Trial
- Hospital System Faces ADA Suit From Medical Marijuana User
- Judge Reluctant To Send J&J Talc Unit's Ch. 11 To 3rd Circ.
- 5th Circ. Questions Basis For Fed. Worker Vax Mandate Freeze
- Attorneys Today Need To Depose Like There's No Tomorrow
- Pharma Co. Says NJ Law Firm Is Misusing Trade Secrets
- States Seek $2.2M In Atty Fees For Joining In Shkreli Case
- NY, NJ Towns Fight $277M 'Hush Money' In Purdue Deal
- Mallinckrodt Inks $260M Deal Ending DOJ Medicaid Claims
- California Pot Regulator Revamps Proposed Cannabis Rules
- Teva Stalled Generics For Blockbuster MS Drug, Buyers Say
- Catching Up With Delaware's Chancery Court
- SPAC CEO Awarded Some Defense Fees For Suits, SEC Probe
- CVS, Walgreens, Walmart Can't Escape Opioid Verdict
- 11th Circ. Says Probation Not Enough For Tricare Fraudster
- Clovis Agrees To Reforms, $2.3M Atty Fee In Drug Trial Suit
- Theranos Judge Trims Jury Pool Over Race Bias, Abuse Views
- Parsing Recent DOJ Statements On Monopolistic Conduct
- Globus' Ex-Sales Rep Says Work Contracts Are Unenforceable
- FCA Trends To Watch For Health, Life Sciences Cos.
- OvaScience, VC Fund Settle Investor Class Action For $15M
- Fed. Circ. Doubts PTAB Wrongly Axed J&J Unit's Surgical IP
- Lab Maker Settles Trade Secrets Suit Against Ex-Executive
- Goodwin Adds Former DOJ Deputy Chief In DC
- Judge Gives First Nod To $4.75M CaptureRx Data Breach Deal
- Mo. Roundup Buyers Say $45M Deal Smells Of Collusion
- Pathway Genomics Investor Says Board Ignored Assets Raid
- 5th Circ. Won't Let States Amend Health Care Vax Challenge
- Valisure Wants Fees For Quashed Subpoena In Zantac MDL
- 7th Circ. Says Suit Alleging Faulty Blood Clot Filter Is Untimely
- Celgene Can't Delay Cancer Drug Antitrust Case, Court Told
- Health Hires: Amylyx, Veracyte
- Athenahealth Whistleblower Wins Fees In $18M Kickback Case
- A Look At This Year's Busy Federal Health Policy Landscape
- Colorado Pharma Co. Investor Sues Over Stock Split, Grant
- Abbott Units Beat Consultant's Training Copyright Suit
- UK Litigation Roundup: Here's What You Missed In London
- Plaintiffs' Bar Irate That J&J's 'Stooge' Ch. 11 Moving Ahead
- Gilead, Teva Look To Trim United Health's HIV Generics Suit
- AmeriHealth Sheds FCA Suit Alleging It Flouted NJ Copay Law
- As EU Unified Patent Court Nears, Companies Mull Opting Out
- IP Forecast: Tech Giants' Voice Tech Row Heads To Fed. Circ.
- AngioDynamics Loses Bid To Pause Patent Row With Bard
- OptumRx Fights To Arbitrate Reimbursement Suit At 3rd Circ.
- Purdue Reaches Final Terms On New $5.5B Ch. 11 Settlement
- Regeneron Can't Ditch COVID-19 Tech Patent Suit
- Illumina Looks To Triple $8M Win For BGI DNA IP Infringement
- Women Make Up Just 12% Of Attys In PTAB Cases
- Express Scripts Can't Avoid MTA Prescription Fraud Claims
- Valero Hit With Suit Over Bay Area Petroleum Coke Pollution
- Industry Insights To Navigate AI Chemical Invention Patents
- Philip Morris Gets Redo On $7M Atty Fee In Engle Suit
- Enforcement Risks For COVID Labs To Identify And Avoid
- Full Fed. Circ. Won't Review Mylan's Win In Symbicort IP Fight
- McCarter & English Accused Of Malpractice Over Biotech IP
- Purdue Mediator Extends Talks To Work On Deal Terms
- 3 Product Liability Highlights From The State Of The Union
- High Court Poised To Make DOJ's Job Harder In Opioid Cases
- The Jackson Ruling That Reverberates In Drug Pricing Debate
- Boston Marriott Says Insured Virus Losses Extended Full Year
- 7th Circ. Says Atty's Mistakes Kept Clients Out Of MDL
- Novartis Patent Suit Over Generic MS Drug Won't Be Trimmed
- Acthar Claimants Seek End To Mallinckrodt Litigation Pause
- IPO Market Appears Stalled For The Near Future
- Feds Expect A Trial For Ex-Theranos Exec As Long As Holmes'
- 3 Firms Rep $200M Life Sciences, Sustainable Tech SPAC IPO
- FDA Says Baby's Death May Be Linked To Abbott Formula
- Fla. Appeals Court Likely To Zero Out $148M Punitive Award
- Chancery Asks If It's Right Venue For Biotech Stock Drop Suit
- How Attorneys Can Ethically Terminate A Client Relationship
- GW Pharmaceuticals Beats CBD Patent Infringement Suit
- Supplement Co.'s False Labeling Settlement Gets First OK
- Broad Institute, MIT Win Patent Battle Over CRISPR